Cargando…
The role of SGLT2i in attenuating residual cardiovascular risk through blood pressure-lowering: mechanistic insights and perspectives
Sodium glucose cotransporter 2 inhibitors (SGLT2) have been increasingly pursued as a promising target for addressing residual cardiovascular risk. Prior trials demonstrated that SGLT2i not only promotes glucose-lowering, but also improves endothelial dysfunction, adiposity, fluid overload, and insu...
Autores principales: | Barreto, Joaquim, Campos-Staffico, Alessandra M., Nadruz, Wilson, Quinaglia, Thiago, Sposito, Andrei C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562622/ https://www.ncbi.nlm.nih.gov/pubmed/37822556 http://dx.doi.org/10.3389/fcdhc.2023.1243530 |
Ejemplares similares
-
Omega-3 intake is associated with attenuated inflammatory response and cardiac remodeling after myocardial infarction
por: Campos-Staffico, Alessandra M., et al.
Publicado: (2019) -
Statin Short-term Inhibition of Insulin Sensitivity and Secretion During Acute Phase of ST-Elevation Myocardial Infarction
por: Sposito, Andrei C., et al.
Publicado: (2019) -
Dopamine receptor agonists mechanism of actions on glucose lowering and their connections with prolactin actions
por: Chien, Hung-Yu, et al.
Publicado: (2023) -
Liraglutide Lowers Palmitoleate Levels in Type 2 Diabetes. A Post Hoc Analysis of the LIRAFLAME Randomized Placebo-Controlled Trial
por: Wretlind, Asger, et al.
Publicado: (2022) -
Dapagliflozin cardiovascular effects on end-stage kidney disease (DARE-ESKD-2) trial: rationale and design
por: Barreto, Joaquim, et al.
Publicado: (2023)